Clinical Trial Update: MIROCALS: Modifying Immune Response and OutComes in ALS [Phase 2]

View source ↗

Summary

MIROCALS is a Phase 2 trial aimed at modifying immune response and outcomes in amyotrophic lateral sclerosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• MIROCALS

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED